EVAX Stock | | | USD 1.19 0.11 8.46% |
Evaxion Biotech financial indicator trend analysis is much more than just examining Evaxion Biotech AS latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evaxion Biotech AS is a good investment. Please check the relationship between Evaxion Biotech Begin Period Cash Flow and its Change To Netincome accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Begin Period Cash Flow vs Change To Netincome
Begin Period Cash Flow vs Change To Netincome Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Evaxion Biotech AS Begin Period Cash Flow account and
Change To Netincome. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Evaxion Biotech's Begin Period Cash Flow and Change To Netincome is -0.64. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Change To Netincome in the same time period over historical financial statements of Evaxion Biotech AS, assuming nothing else is changed. The correlation between historical values of Evaxion Biotech's Begin Period Cash Flow and Change To Netincome is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Evaxion Biotech AS are associated (or correlated) with its Change To Netincome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Netincome has no effect on the direction of Begin Period Cash Flow i.e., Evaxion Biotech's Begin Period Cash Flow and Change To Netincome go up and down completely randomly.
Correlation Coefficient | -0.64 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Change To Netincome
Most indicators from Evaxion Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evaxion Biotech AS current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
Issuance Of Capital Stock is likely to rise to about 15.2
M in 2024, whereas
Tax Provision is likely to drop (825.3
K) in 2024.
Evaxion Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Evaxion Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evaxion Biotech fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to
measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to
predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.